⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37443 | 0.70 | — | — | |
| SCHEMBL18917588 | 0.60 | — | — | |
| Formaldehyde SCHEMBL5022874 | 0.60 | — | — | |
| SCHEMBL7240952 | 0.59 | — | — | |
| SCHEMBL1296 | 0.59 | — | — | |
| SCHEMBL28095 | 0.59 | — | — | |
| SCHEMBL10940023 | 0.59 | — | — | |
| SCHEMBL45125 | 0.59 | — | — | |
| SCHEMBL1331944 | 0.59 | — | — | |
| Water SCHEMBL2929026 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025119216-A1 | BORONIC ACID β-LACTAMASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | 珠海联邦制药股份有限公司 | 2025-06-12 | — | — | WO | claimed |
| CN-118613286-A | GPC3 antibody drug conjugates and uses thereof | 映恩生物制药（苏州）有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-118525011-A | Morpholinyl quinazoline compound, preparation method and application thereof | 上海璎黎药业有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-118434453-A | Her3 antibody drug conjugate and application thereof | 映恩生物制药（苏州）有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-114173915-B | Film and polymer for producing same | 索尔维特殊聚合物美国有限责任公司 | 2024-05-31 | — | — | CN | claimed |
| CN-117285626-A | Alpha v beta 6 integrin ligand and its application | 箭头药业股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-117043151-A | Pyrimidine or pyridine derivative and medical application thereof | 希格生科（深圳）有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-116924998-A | Preparation method and application of substituted phenyl pyrimidine guanidine compound | 沈阳农业大学 | 2023-10-24 | — | — | CN | claimed |
| CN-109952376-B | Alpha v beta 6 integrin ligand and its application | 箭头药业股份有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116496271-A | Piperazinyl-containing compounds | 正大天晴药业集团股份有限公司 | 2023-07-28 | — | — | CN | claimed |
| WO-2023109751-A1 | PYRIMIDINE OR PYRIDINE DERIVATIVE AND MEDICINAL USE THEREOF | 希格生科（深圳）有限公司 | 2023-06-22 | — | — | WO | claimed |
| WO-2022268152-A1 | GLP-1 RECEPTOR AGONIST AND COMPOSITION AND USE THEREOF | 杭州中美华东制药有限公司 | 2022-12-29 | — | — | WO | claimed |
| CN-111808056-B | Dopamine D 2 Receptor selective agonists and their use in the treatment of disease | 中国科学院分子细胞科学卓越创新中心 | 2022-08-23 | — | — | CN | claimed |
| WO-2022171135-A1 | SPIRO-CONTAINING QUINAZOLINE DERIVATIVE | 微境生物医药科技(上海)有限公司 | 2022-08-18 | — | — | WO | claimed |
| JP-2034608-A | — | — | None | — | — | JP | disclosed |
| CN-122071464-A | Heterocyclic compound, pharmaceutical composition thereof and application thereof | 上海璎黎药业有限公司 | 2026-05-22 | — | — | CN | disclosed |
| US-20260042077-A1 | PROTON-RICH IONIC FLUID SYSTEMS AND METHODS | TegIpco, LLC (US) | 2026-02-12 | — | — | US | disclosed |
| CN-1006464-B | PROCESS FOR PREPARING NAPHTHALENE DERIVATIVES | TANABE SEIYAKU CO (JP) | 1990-01-17 | — | — | CN | disclosed |
| CN-86100090-A | The preparation method of naphthalene derivatives | — | 1986-08-20 | — | — | CN | disclosed |
| JP-H00234608-A | — | — | 0001-01-01 | — | — | JP | disclosed |